Keith Regnante

Affiliations

  • Chief Financial Officer at Keros Therapeutics Inc. (KROS), 2024-02-16
  • Chief Financial Officer at Wave Life Sciences Ltd. (WVE), 2019-03-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KROS $45.29 40,000 Officer 0 2023-11-04 Filing
KROS $47.25 2,579 Officer 0 2023-06-09 Filing
KROS $46.46 1,428 Officer 2,579 2023-06-09 Filing
KROS $45.03 15,993 Officer 4,007 2023-06-09 Filing
KROS $48.65 2,699 Officer 0 2023-06-08 Filing